FDA Approval Could Send This Stock Soaring

Whenever the FDA approves a new drug... Timely investors could see 300-400% returns... ChemoCentryx soared 281% in the year after it won FDA approval... Immunogen jumped 449% in the two years after it won FDA approval... Even Krystal Biotech rose 242% when it looked like it would win FDA approval, which it did.

What's Going On With Amazon Stock Tuesday?

Evette Mitkov
September 30, 2025

Amazon.com Inc (NASDAQ:AMZN) shares are trading lower on Tuesday despite multiple positive catalysts, including a new partnership with FanDuel and a bullish analyst initiation from Mizuho.

What Happened: Lloyd Walmsley at Mizuho initiated coverage on the e-commerce giant on Tuesday with an Outperform rating and price target of $300, suggesting substantial potential gains from current levels.

Wall Street’s collective view has assigned Amazon an average price target of $263.32. The three most recent analyst updates from Mizuho, Telsey Advisory Group and Wells Fargo have an average target of $281.67, representing 28.67% upside.

Separately, Amazon revealed a collaboration making FanDuel the exclusive odds provider for NBA and WNBA content on Prime Video. The partnership will also feature real-time bet tracking capabilities designed to increase audience engagement and ad revenue.

Despite the positive analyst initiation and partnership news, Amazon stock is moving lower. The company is holding a launch event for new hardware devices on Tuesday, which may be impacting shares. Amazon announced new smart speakers, Kindles, TVs and cameras, and introduced its new AI-powered Alexa.

It’s also worth noting that Elon Musk recently posted on X that winning the AI race “was never in the set of possible outcomes for Anthropic,” which may be raising investor concerns. Amazon has invested approximately $8 billion in Anthropic to date.

How To Buy AMZN Stock

By now you're likely curious about how to participate in the market for Amazon – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

AMZN Price Action: Amazon shares are down by 1.33% at $219.05 at the time of publication on Tuesday, according to Benzinga Pro.

Read Next:

  • Deregulation May Hurt Retail Traders But Brokerages Stand To Benefit; Expect More Unexpected Bankruptcies

Image: Markus Mainka/Shutterstock.com

Continue Reading...

Popular

Helen Mirren opens Stella McCartney’s activist, cruelty-free Paris runway

PARIS (AP) — Inside the Centre Pompidou, opened ’s Paris Fashion Week show with a spoken rendition of ’ “Come Together.” Less performance than manifesto, it set the tone for a Tuesday night collection framed around humanity, animals and Mother Earth.

A robot programmed to act like a 7-year-old girl works to combat fear and loneliness in hospitals

Days after Meagan Brazil-Sheehan’s 6-year-old son was diagnosed with leukemia, they were walking down the halls of UMass Memorial Children’s Medical Center when they ran into Robin the Robot.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

George Soros-Backed Kodiak Robotics Merger Funding Announcement Fuels 6% After-Hours Rally In This SPAC Stock

Ares Acquisition Corporation II shares jumped 6.42% after hours following a successful $275M funding announcement for its merger with Kodiak Robotics.

Donald Trump's Approval Rating Crashes to Record Low — Here's What's Driving the Decline

According to the recent YouGov/Economist poll, President Trump's approval rating has taken a nosedive, reaching its lowest point in his second term.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Pilgrims turn Spain's Santiago de Compostela into the world's latest overtourism flashpoint

SANTIAGO DE COMPOSTELA, Spain (AP) — While some Barcelona residents sought to repel a tsunami of tourists , a neighborhood association in Santiago de Compostela opted for a friendlier approach: a guide to good manners for visitors to their town, the endpoint of the Catholic world's most famous pilgrimage.

It's 'do or die' for electric vehicle maker Rivian as it breaks ground on a $5 billion plant

ATLANTA (AP) — It seems like a terrible time to build an electric vehicle plant in the United States, but Rivian Automotive leaders say they're confident as the company starts on a $5 billion facility in Georgia.

The First Public Cash-Flowing Digital Treasury - Ad

Unlike Bitcoin vaults, this NASDAQ-listed company earns yield through BNB staking and nodes. $368M already deployed, still overlooked.

Warner Bros. Discovery Stock Takes Off As Paramount Skydance Eyes Takeover

Warner Bros. Discovery's stock jumps more than 28% on Thursday—its biggest single-day gain ever.

TikTok Stays Online As Trump Extends US Deadline, Washington Still Demands ByteDance Divestment

President Trump said he and Chinese President Xi Jinping made progress on a TikTok deal and will meet in South Korea in just over a month.

We've Seen This Before... and It Didn't End Well - Ad

Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.

Fallout from cyberattack on check-in systems at 3 European airports continues for 2nd day

BRUSSELS (AP) — Fallout from a cyberattack that affected check-in systems at several European airports extended into a second full day on Sunday, as passengers faced dozens of cancelled and delayed flights and airport teams scrambled to limit the damage to travel plans.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Labor Dispute Eases As UAW, GE Aerospace Agree On Tentative Pact

UAW members at GE Aerospace plants in Ohio and Kentucky reached a tentative deal, with a ratification vote set for Sept. 19.

Digital Gold. Digital Oil. Digital Infrastructure. - Ad

Bitcoin and Ethereum had their turn. Now a NASDAQ-listed firm is scaling BNB, which fuels 290M users and pays yield.

Trump Links Sanctions On Russia To NATO Unity, Calls Out Hungary And Slovakia Over Oil Purchases

Trump stated that sanctions on Russia would only be imposed if all NATO countries agree to identical measures and halt Russian oil purchases.

Hillary Clinton Says Trump Administration Is 'Going Great' For The President, Dogecoin Rallies 20%, Silver Token Tops Bitcoin — This Week In Crypto

The past week has been a rollercoaster ride in the world of finance and politics. From silver-backed cryptocurrencies outperforming Bitcoin (CRYPTO: BTC) to Hillary Clinton’s accusations of crypto corruption against the Trump administration, there’s been no shortage of headlines.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

A United Airlines passenger plane makes emergency landing in Osaka as cargo fire is suspected

NAGASAKI, Japan (AP) — A United Airlines passenger plane carrying 142 people and bound for the Philippine island of Cebu made an emergency landing in Osaka on Friday after an indicator showed a fire in the cargo room, Japanese aviation officials said.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

New York City's Wealthiest Neighborhoods Witness 60% Rent Surge Since Pandemic

House rental rates in some of the wealthiest neighborhoods of New York City have surged by over 60% since the COVID-19 pandemic began, putting even high-income earners in a tight spot.

The Next Evolution in Public Treasuries - Ad

MicroStrategy proved the model with BTC. Now a NASDAQ-listed firm is running it with BNB, yield, and 290M users. $368M locked in.

Rigetti Computing Stock Soars On $5.8 Million Air Force Contract

Rigetti Computing Inc (NASDAQ:RGTI) shares are gaining traction on Thursday after the company announced a major quantum networking contract.

Europe's Ryder Cup team uses VR headsets to prepare for noise and insults at Bethpage Black

VIRGINIA WATER, England (AP) — Whatever heckling European players might face at the Ryder Cup in New York could be what they already have heard before, all because of virtual reality headsets that Rory McIlroy says can be adjusted to hear the harshest abuse.

FDA Approval Could Send This Stock Soaring - Ad

Whenever the FDA approves a new drug... Timely investors could see 300-400% returns... ChemoCentryx soared 281% in the year after it won FDA approval... Immunogen jumped 449% in the two years after it won FDA approval... Even Krystal Biotech rose 242% when it looked like it would win FDA approval, which it did.

Economists Warn 'Stagflation Is In The Room' Amid Interest Rate Cut News: 'The Fed Has No Idea Where Inflation Will Be,' Says Peter Schiff

Leading economists are reacting to the Federal Reserve's decision to cut interest rates by 25 basis points on Wednesday, with some lauding the central bank's independence, and others warning of difficult times ahead.

Gemini Upsizes IPO To Raise $425 Million, Winklevoss Twins-Founded Crypto Exchange Targets $3 Billion Valuation

Cryptocurrency exchange Gemini raised $425 million in an initial public offering, pricing its shares above the expected range, according to an announcement made late Thursday.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Venezuelan president's YouTube account offline as tensions with US escalate

BOGOTA, Colombia (AP) — The YouTube account of was offline Saturday, with Venezuelan state-run channel Telesur claiming in a message on X that it was “eliminated” late the previous night without justification.

Embed-Chart-Consumer Prices, ADVISORY

CONSUMER PRICES — Chart. This AP digital embed chart shows the percentage change in consumer prices from the previous year, as measured by the consumer price index, since 2010. In August, consumer prices rose 2.9%, up from July's 2.7% figure. Excluding food and energy, prices rose 3.1% from the previous year, unchanged from July. This chart is current as of Sept. 11, 2025, and will update monthly. Source: Bureau of Labor Statistics.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Lam Research And JSR Resolve Legal Disputes As They Team Up On AI Era Chips

Lam Research and JSR Corp agreed to collaborate and cross-license, combining their expertise to accelerate semiconductor manufacturing and reduce costs.

Nio, Rivian, Moderna, Meta And Bitmine Immersion: Why These 5 Stocks Are On Investors' Radars Today

On Tuesday, U.S. markets slipped, with the Dow Jones Industrial Average falling about 0.3% to 45,757.90, the S&P 500 retreating 0.1% to 6,606.76, and the Nasdaq edging down 0.07% to 22,333.96.These are the top stocks that gained the attention of retail traders and investors throughout the day.

The First Public Cash-Flowing Digital Treasury - Ad

Unlike Bitcoin vaults, this NASDAQ-listed company earns yield through BNB staking and nodes. $368M already deployed, still overlooked.

US official sees Greece as hub to boost American natural gas exports

ATHENS, Greece (AP) — A U.S. Cabinet official overseeing a planned expansion of natural gas exports to Europe said Thursday that could play a key role through its pipeline system that extends across the region.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright finstrategist.com
Privacy Policy | Terms of Service